Post COVID-19 Mucormycosis in Mandible-Case Report of Two Rare Cases
Published: 2023-02-28
Page: 40-47
Issue: 2023 - Volume 6 [Issue 2]
Sanjay Yadav *
Oral Maxillofacial Pathology and Oral Microbiology, Government Dental College and Hospital, Gujarat University, Ahmedabad, Gujarat, India.
Namrata Jayasheel
Oral Maxillofacial Pathology and Oral Microbiology, Government Dental College and Hospital, Gujarat University, Ahmedabad, Gujarat, India.
Sima Odedra
Oral Maxillofacial Pathology and Oral Microbiology, Government Dental College and Hospital, Gujarat University, Ahmedabad, Gujarat, India.
Piyush Asnani
Oral Maxillofacial Pathology and Oral Microbiology, Government Dental College and Hospital, Gujarat University, Ahmedabad, Gujarat, India.
*Author to whom correspondence should be addressed.
Abstract
Mucormycosis, also known as black fungus, is a fulminant fungal infection that is reported most often in diabetic and immunocompromised individuals is a life-threatening, invasive fungal infection. After the COVID-19 pandemic, there was a significant rise in the Mucormycosis cases reported in the Maxillofacial region which was attributed to the unbalanced use of steroids to avoid the cytokine storm in covid patients. The majority of the cases reported were of rhinocerebral/orbital or maxillary areas. Very few reports describing the Muromycosis involving mandible have been published on the online database. So here, in this case, report a brief of two cases of Mucormycosis involving the mandible have been described its clinical presentation and histopathologic features.
Keywords: Mandibular Mucor, COVID associated mucormycosis, diabetic, maxillofacial infection